Effectiveness and Safety/Tolerability of Eslicarbazepine Acetate in Epilepsy Patients Aged ≥ 60 Versus < 60 Years: A Subanalysis from the Euro-Esli Study

Effectiveness and Safety/Tolerability of Eslicarbazepine Acetate in Epilepsy Patients Aged ≥ 60 Versus < 60 Years: A Subanalysis from the Euro-Esli Study

Abstract Introduction Clinical practice studies help guide antiepileptic drug (AED) therapy in patient groups routinely excluded from clinical trials, such as the elderly. The Euro-Esli study investigated the effectiveness and safety/tolerability of eslicarbazepine acetate (ESL) when used in everyda...

Full description

Bibliographic Details
Main Authors: Charlotte Lawthom, Pedro Bermejo, Dulce Campos, Rob McMurray, Vicente Villanueva
Format: Article
Language:English
Published: Adis, Springer Healthcare 2019-05-01
Series:Neurology and Therapy
Subjects:
Clinical practice
Elderly
Epilepsy
Eslicarbazepine acetate
Euro-Esli
Focal epilepsy
Online Access:http://link.springer.com/article/10.1007/s40120-019-0137-0

Internet

http://link.springer.com/article/10.1007/s40120-019-0137-0

Similar Items